Summit Therapeutics Inc. ( SMMT) - Stock Earnings
SMMT Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -231.8 million USD | — USD |
| 2025Q4 | -219.2 million USD | — USD |
| 2026Q1 | -189.4 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
SMMT Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -482.4 million USD | 704295 USD |
| 2024 | -176.8 million USD | — USD |
| 2025 | -1.1 billion USD | — USD |
| 2026 Est. | — | — |
SMMT
Price: $14.32
52 week price:
Earnings Per Share: -1.59 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 252593
Ebitda: -3.9 millionMarket Capitalization: 11.7 billion